Literature DB >> 35673424

Do patients with diabetic foot ulcer need booster dose of tetanus vaccine?

Zahra Hoseini Tavassol1, Zahra Sajjadpour1, Shirin Hasani-Ranjbar1, Mahnaz Pejman Sani2, Hamidreza Aghaei Meybodi3, Bagher Larijani2.   

Abstract

Purpose: Diabetic foot ulcer is a public health concern around the world. These wounds are prone to a variety of infections including Clostridium Tetani that may lead to tetanus. The aim of this study was to evaluate the immunity status as a result of tetanus vaccination and other preventive measures in these patients.
Methods: We conducted a narrative review of previous studies which were related to the risk of tetanus infection in diabetic foot patients by searching electronic databases.
Results: It was found that usually tetanus antibody titers in diabetic patients are below the protective level and they are not appropriately vaccinated. Therefore, diabetes and lack of immunity, put diabetic foot ulcer patients more at risk of tetanus. But this problem is not given serious attention in diabetes care. Conclusions: Thus, it is recommended to provide specific guidelines for tetanus vaccination and prophylaxis in diabetic patients. These recommendations can play a vital role in the prevention of diabetic foot ulcers complication. © Springer Nature Switzerland AG 2021.

Entities:  

Keywords:  Diabetic foot ulcer; Tetanus; Tetanus prophylaxis; Tetanus vaccination

Year:  2022        PMID: 35673424      PMCID: PMC9167406          DOI: 10.1007/s40200-021-00966-1

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  27 in total

1.  Immunity to diphtheria and tetanus in England and Wales.

Authors:  P A Maple; C S Jones; E C Wall; A Vyseb; W J Edmunds; N J Andrews; E Miller
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

2.  Tetanus in patients with chronic wounds - are we aware?

Authors:  Elizabeth Farnworth; Awen Roberts; Aravindan Rangaraj; Uzma Minhas; Samantha Holloway; Keith Harding
Journal:  Int Wound J       Date:  2011-09-19       Impact factor: 3.315

Review 3.  Tetanus complicating a polymicrobial diabetic foot infection: case presentation and review of current treatment.

Authors:  D B Thordarson; J R Perry; M J Patzakis
Journal:  Foot Ankle Int       Date:  1995-02       Impact factor: 2.827

4.  Chronic ulcers and myasis as ports of entry for Clostridium tetani.

Authors:  J B Greco; E Sacramento; J Tavares-Neto
Journal:  Braz J Infect Dis       Date:  2003-02-21       Impact factor: 1.949

5.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

6.  Impaired immunity against tetanus in type 2 diabetes.

Authors:  Ali Tamer; Oguz Karabay; Hasan Ekerbicer; Mustafa Tahtaci; Belgin Selam; Harika Celebi
Journal:  Med Sci Monit       Date:  2005-11-24

Review 7.  Prevention and treatment of diabetic foot ulcers.

Authors:  Jonathan Zhang Ming Lim; Natasha Su Lynn Ng; Cecil Thomas
Journal:  J R Soc Med       Date:  2017-01-24       Impact factor: 5.344

Review 8.  The diabetic foot: Pathophysiology, evaluation, and treatment.

Authors:  Dennis F Bandyk
Journal:  Semin Vasc Surg       Date:  2019-02-06       Impact factor: 1.000

9.  A population-based serologic survey of immunity to tetanus in the United States.

Authors:  P J Gergen; G M McQuillan; M Kiely; T M Ezzati-Rice; R W Sutter; G Virella
Journal:  N Engl J Med       Date:  1995-03-23       Impact factor: 91.245

Review 10.  Foot ulcers in the diabetic patient, prevention and treatment.

Authors:  Stephanie C Wu; Vickie R Driver; James S Wrobel; David G Armstrong
Journal:  Vasc Health Risk Manag       Date:  2007
View more
  1 in total

1.  Tetanus in Uganda: Clinical Outcomes of Adult Patients Hospitalized at a Tertiary Health Facility Between 2011 and 2020.

Authors:  Andrew Kazibwe; Noah Emokol Okiror; Felix Bongomin; Amelia Margaret Namiiro; Joseph Baruch Baluku; Robert Kalyesubula; Magid Kagimu; Irene Andia-Biraro
Journal:  Open Forum Infect Dis       Date:  2022-07-25       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.